Journal History
| Event | Date | Details |
|---|---|---|
| Establishment of COMORBID | January 10, 2022 |
The PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID) was established under the leadership of editor-in-chief Dr. Nicholas Chally Tirayoh. All papers are double blind peer-reviewed and published four times a year that is in January, April, July and October of every year. |
| e-ISSN Registration | January 17, 2022 | The e-ISSN was successfully registered with the number 2809-9745. |
| Indexing List | 2022 | COMORBID Journal started to be indexed in following index: - Google Schoolar - GARUDA - Scilit - DIMENSION - WORLDCAT - others |
| Crossref Registration | January 2022 | COMORBID began the registration process with Crossref. |
| DOI Assignment | January 2022 | COMORBID was assigned a DOI: https://doi.org/10.55047/comorbid |
| Manuscripts Language Policy | January 2022 | From the very beginning (Vol. 1 No.1), the COMORBID accepted manuscripts in English |
| COMORBID Volume 1 | 2022 |
Vol. 1 No. 1 (2022) JANUARY |
| ICI index | 2022 |
COMORBID was Indexed in the ICI Journals Master List 2022 see ICV 2022 value |
| 2023 | ||
| COMORBID Volume 2 | 2023 |
Vol. 2 No. 1 (2023) JANUARY |
| ICI index | 2023 |
COMORBID was Indexed in the ICI Journals Master List 2023 with ICV 2023: 90.13 |
| Editorial Board Involvement | October 2023 | Since Volume 2, Issue 4, several members of the Editorial Board have screened articles and collaborated with reviewers from institutions in Indonesia and Malaysia. |
| 2024 | ||
| Volume 3 | 2024 |
Vol. 3 No. 1 (2024) JANUARY |
| 2025 | ||
| ICI index | September 4, 2025 |
COMORBID was Indexed in the ICI Journals Master List 2024 with ICV 2024: 96.13 |
| Template Change | 2025 |
Beginning with Vol. 4 (2025) new cover and template was introduced, incorporating the history of the manuscript, DOI, and an open access logo |
| Volume 4 | 2025 | Vol. 4 No. 1 (2025) JANUARY Vol. 4 No. 2 (2025) APRIL Vol. 4 No. 3 (2025) JULY Vol. 4 No. 4 (2025) OCTOBER |
| SINTA 3 Accreditation | March 24, 2025 | COMORBID has been accredited as SINTA 3 by the Directorate General of Research and Development, Ministry of Higher Education, Science and Technology of the Republic of Indonesia. Accreditation is valid from Volume 1, Issue 1 (2022) until Volume 5, Issue 2 (2026) under Decree No. 10/C/C3/DT.05.00/2025 |
| Indexing Process | Ongoing | The COMORBID journal continues to maintain high-quality standards as part of its preparation for indexing in SINTA (re-acreditation), DOAJ, and other reputable databases. |